Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
3
×
national blog main
national top stories
san diego blog main
san diego top stories
san francisco blog main
amgen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drugs
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alder biopharmaceutical
alirocumab
allergan
american academy of neurology
atogepant
avalon ventures
biohaven
bob azelby
botox
brian abrahams
calcitonin gene-related peptide
What
drug
3
×
drugs
3
×
new
3
×
advance
approval
arguments
big
biologic
biology
cholesterol
class
commercialized
companies
competitors
cytokine
decades
demonstrating
diego’s
enhanced
expensive
faces
fda
financial
foe
healthcare
hint
inhibitors
known
lead
lowering
make
meeting
migraine
neuro
oral
pcsk
potential
produce
raises
remember
Language
unset
Current search:
new
×
drug
×
drugs
×
" life sciences "
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs